BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4869694)

  • 1. Studies in mice of the action of DDS against Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1967; 35(4):616-24. PubMed ID: 4869694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
    Millan J; Moulia-Pelat JP
    Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of drugs against Mycobacterium leprae studied in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
    [No Abstract]   [Full Text] [Related]  

  • 4. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 7. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDS sensitivity of mycobacteria. Antagonistic effect of PABA for M. ulcerans and M. kansasii.
    Pattyn SR; van Ermengem J
    Int J Lepr Other Mycobact Dis; 1968; 36(4):427-31. PubMed ID: 5753812
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of compound TH 270 (N-p-isobutoxyphenyl-N'-p'- -pyridyl-ethyl-phenylthiourea) on the experimental infection with Mycobacterium lepraemurium and Mycobacterium leprae.
    Pattyn SR; Wagner WH
    Ann Soc Belg Med Trop; 1972; 52(1):55-61. PubMed ID: 4621868
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechansism of action of DDS.
    Hasting RC
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):65. PubMed ID: 6988348
    [No Abstract]   [Full Text] [Related]  

  • 12. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse footpad test--sensitive to small proportions of drug-resistant bacilli in a sample of M. leprae.
    Almeida JG; Joseph PS; Sarangapani G; Chacko CJ
    Indian J Lepr; 1984; 56(1):10-4. PubMed ID: 6384379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 15. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problem of dapsone-resistant leprosy.
    Pearson JM
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone-resistant leprosy-the THELEP approach.
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):421-5. PubMed ID: 7042606
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
    Seydel JK; Richter M; Wempe E
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):18-29. PubMed ID: 6988345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.